Standout Papers

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group... 2006 2026 2012 2019 1.7k
  1. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group (2008)
    Jean‐Pierre Pignon, Hélène Tribodet et al. Journal of Clinical Oncology
  2. DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy (2006)
    Ken A. Olaussen, Ariane Dunant et al. New England Journal of Medicine
  3. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study (2007)
    Maja Mockenhaupt, Cécile Viboud et al. Journal of Investigative Dermatology
  4. ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis (2010)
    B. Sassolas, Cynthia Haddad et al. Clinical Pharmacology & Therapeutics

Immediate Impact

26 from Science/Nature 65 standout
Sub-graph 1 of 19

Citing Papers

Cell–extracellular matrix mechanotransduction in 3D
2023 Standout
Transfer learning enables predictions in network biology
2023 StandoutNature
1 intermediate paper

Works of Ariane Dunant being referenced

Value of whole breast magnetic resonance elastography added to MRI for lesion characterization
2017
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout

Author Peers

Author Last Decade Papers Cites
Ariane Dunant 3607 3008 1326 2179 82 8.3k
Daniel D. Karp 3760 4694 1571 605 213 9.2k
Jean‐Pierre Armand 2015 3673 816 339 161 6.8k
Ronit Simantov 4224 3293 2630 134 87 11.0k
Steven G. DuBois 2614 1965 1462 192 275 7.1k
D L Trump 1606 1977 398 196 73 4.7k
Nigel Bundred 1148 4639 3032 268 170 8.7k
E. Wiltshaw 1342 2739 305 135 128 7.3k
Giampietro Gasparini 1433 4031 3386 394 167 9.6k
Graça M. Dores 1836 2835 1123 84 83 7.9k
A.T. van Oosterom 2865 3735 799 97 176 7.7k

All Works

Loading papers...

Rankless by CCL
2026